• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用阿尔茨海默病评估联盟测试的泰语版评估轻度认知障碍的特征:一项多元和机器学习研究。

Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.

机构信息

Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

Dement Geriatr Cogn Disord. 2018;45(1-2):38-48. doi: 10.1159/000487232. Epub 2018 Apr 4.

DOI:10.1159/000487232
PMID:29617684
Abstract

BACKGROUND

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) developed a neuropsychological battery (CERAD-NP) to screen patients with Alzheimer's dementia. Mild cognitive impairment (MCI) has received attention as a pre-dementia stage.

OBJECTIVES

To delineate the CERAD-NP features of MCI and their clinical utility to externally validate MCI diagnosis.

METHODS

The study included 60 patients with MCI, diagnosed using the Clinical Dementia Rating, and 63 normal controls. Data were analysed employing receiver operating characteristic analysis, Linear Support Vector Machine, Random Forest, Adaptive Boosting, Neural Network models, and t-distributed stochastic neighbour embedding (t-SNE).

RESULTS

MCI patients were best discriminated from normal controls using a combination of Wordlist Recall, Wordlist Memory, and Verbal Fluency Test. Machine learning showed that the CERAD features learned from MCI patients and controls were not strongly predictive of the diagnosis (maximal cross-validation 77.2%), whilst t-SNE showed that there is a considerable overlap between MCI and controls.

CONCLUSIONS

The most important features of the CERAD-NP differentiating MCI from normal controls indicate impairments in episodic and semantic memory and recall. While these features significantly discriminate MCI patients from normal controls, the tests are not predictive of MCI.

摘要

背景

阿尔茨海默病注册研究联盟(CERAD)开发了一种神经心理学测试工具(CERAD-NP),用于筛查阿尔茨海默病患者。轻度认知障碍(MCI)作为一种痴呆前阶段受到了关注。

目的

描述 MCI 的 CERAD-NP 特征及其临床应用,以对外验证 MCI 诊断。

方法

该研究纳入了 60 名 MCI 患者(采用临床痴呆评定量表进行诊断)和 63 名正常对照者。采用受试者工作特征分析、线性支持向量机、随机森林、自适应提升、神经网络模型和 t 分布随机近邻嵌入(t-SNE)进行数据分析。

结果

使用词汇回忆、词汇记忆和语言流畅性测验的组合可以最佳地区分 MCI 患者和正常对照者。机器学习显示,从 MCI 患者和对照组中学习到的 CERAD 特征对诊断的预测性不强(最大交叉验证 77.2%),而 t-SNE 显示 MCI 和对照组之间存在相当大的重叠。

结论

区分 MCI 和正常对照组的 CERAD-NP 最重要的特征表明存在情节记忆和语义记忆及回忆受损。虽然这些特征可以显著区分 MCI 患者和正常对照组,但这些测试不能预测 MCI。

相似文献

1
Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.使用阿尔茨海默病评估联盟测试的泰语版评估轻度认知障碍的特征:一项多元和机器学习研究。
Dement Geriatr Cogn Disord. 2018;45(1-2):38-48. doi: 10.1159/000487232. Epub 2018 Apr 4.
2
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.两种言语记忆测量方法联合应用对阿尔茨海默病所致轻度认知障碍的诊断及预后价值
J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073.
3
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.生物标志物组合对预测轻度认知障碍向阿尔茨海默病痴呆进展的增量价值。
Alzheimers Res Ther. 2017 Oct 10;9(1):84. doi: 10.1186/s13195-017-0301-7.
4
Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.在一个受早老素-1基因E280A突变影响的轻度认知障碍和阿尔茨海默病的哥伦比亚队列中,CERAD总分的诊断准确性。
Int Psychogeriatr. 2016 Mar;28(3):503-10. doi: 10.1017/S1041610215001660. Epub 2015 Oct 19.
5
CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.遗忘型轻度认知障碍和阿尔茨海默病中的CERAD测试表现。
Acta Neurol Scand. 2005 Mar;111(3):172-9. doi: 10.1111/j.1600-0404.2005.00380.x.
6
CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.CERAD 神经心理学复合评分能准确检测前驱期阿尔茨海默病:一项前瞻性 AddNeuroMed 研究。
J Alzheimers Dis. 2014;39(3):679-90. doi: 10.3233/JAD-122110.
7
CERAD-neuropsychological battery in screening mild Alzheimer's disease.CERAD 神经心理学成套测验在轻度阿尔茨海默病筛查中的应用。
Acta Neurol Scand. 2012 Jan;125(1):16-23. doi: 10.1111/j.1600-0404.2010.01459.x. Epub 2011 Jan 4.
8
[Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].[轻度认知障碍与阿尔茨海默病:CERAD-NP测试组合的研究]
Fortschr Neurol Psychiatr. 2005 Oct;73(10):568-76. doi: 10.1055/s-2004-830249.
9
Diagnostic value of digital clock drawing test in comparison with CERAD neuropsychological battery total score for discrimination of patients in the early course of Alzheimer's disease from healthy individuals.数字时钟绘画测试与 CERAD 神经心理学成套测验总分在鉴别阿尔茨海默病早期患者与健康个体中的诊断价值比较。
Sci Rep. 2019 Mar 5;9(1):3543. doi: 10.1038/s41598-019-40010-0.
10
Comparison of verbal episodic memory measures: consortium to establish a registry for Alzheimer's disease--Neuropsychological Assessment Battery (CERAD-NAB) versus California Verbal Learning Test (CVLT).口头情节记忆测量的比较:建立阿尔茨海默病登记册的联合会——神经心理学评估成套测验(CERAD-NAB)与加利福尼亚词语学习测验(CVLT)。
Arch Clin Neuropsychol. 2012 Aug;27(5):510-9. doi: 10.1093/arclin/acs056. Epub 2012 Jun 19.

引用本文的文献

1
Development and interpretation of a machine learning predictive model for early cognitive impairment in hypertension associated with environmental factors.基于环境因素的高血压早期认知功能障碍机器学习预测模型的建立与解读
Front Cardiovasc Med. 2025 Aug 29;12:1477185. doi: 10.3389/fcvm.2025.1477185. eCollection 2025.
2
Proteomic associations with cognitive variability as measured by the Wisconsin Card Sorting Test in a healthy Thai population: A machine learning approach.泰国健康人群中通过威斯康星卡片分类测验测量的蛋白质组学与认知变异性的关联:一种机器学习方法。
PLoS One. 2025 Feb 20;20(2):e0313365. doi: 10.1371/journal.pone.0313365. eCollection 2025.
3
Cytokine dysregulation in amnestic mild cognitive impairment.
遗忘型轻度认知障碍的细胞因子失调。
Sci Rep. 2024 Sep 28;14(1):22486. doi: 10.1038/s41598-024-73099-z.
4
Neurocognitive Features of Mild Cognitive Impairment and Distress Symptoms in Older Adults Without Major Depression.老年人轻度认知障碍与无重度抑郁的困扰症状的神经认知特征。
Clin Interv Aging. 2024 Aug 21;19:1445-1459. doi: 10.2147/CIA.S473730. eCollection 2024.
5
Prediction Model for Cognitive Impairment among Disabled Older Adults: A Development and Validation Study.残疾老年人认知障碍预测模型:一项开发与验证研究。
Healthcare (Basel). 2024 May 15;12(10):1028. doi: 10.3390/healthcare12101028.
6
Distress Symptoms of Old Age and Mild Cognitive Impairment are Two Distinct Dimensions in Older Adults Without Major Depression.老年期的痛苦症状和轻度认知障碍是无重度抑郁症的老年人的两个不同维度。
Psychol Res Behav Manag. 2024 Jan 6;17:101-116. doi: 10.2147/PRBM.S447774. eCollection 2024.
7
CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.CERAD(阿尔茨海默病研究联盟)神经心理学评估工具包:35 年的历程与展望。
J Alzheimers Dis. 2023;93(1):1-27. doi: 10.3233/JAD-230026.
8
Random Forest Model in the Diagnosis of Dementia Patients with Normal Mini-Mental State Examination Scores.简易精神状态检查表评分正常的痴呆患者诊断中的随机森林模型
J Pers Med. 2022 Jan 4;12(1):37. doi: 10.3390/jpm12010037.
9
Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review.利用临床数据进行阿尔茨海默病痴呆症进展建模的机器学习:系统文献综述
JAMIA Open. 2021 Aug 2;4(3):ooab052. doi: 10.1093/jamiaopen/ooab052. eCollection 2021 Jul.
10
Unearthing of Key Genes Driving the Pathogenesis of Alzheimer's Disease via Bioinformatics.通过生物信息学挖掘驱动阿尔茨海默病发病机制的关键基因
Front Genet. 2021 Apr 16;12:641100. doi: 10.3389/fgene.2021.641100. eCollection 2021.